The global dialysis equipment market size is predicted to increase from USD 20.16 billion in 2024, grew to USD 21.2 billion in 2025 and is anticipated to reach around USD 33.25 billion by 2034, poised to grow at a CAGR of 5.13% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Dialysis Equipment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dialysis Equipment Market Revenue and Volume, by Product Type, 2024-2034
8.1.1. Hemodialysis Equipment
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Peritoneal Dialysis Equipment
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Other
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Dialysis Equipment Market Revenue and Volume, by End-User, 2024-2034
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Dialysis Centers
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Homecare Settings
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.1. Nxstage Medical, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Medivators Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Asahi Kasei Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Nikkiso Co., Ltd.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Nipro
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Medtronic
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Isopure Corp.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Fresenius Medical Care AG & Co. KGaA
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Dialife
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Diaverum
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample